- Home
- WWW vs INBX Comparison
WWW vs INBX Comparison
Compare WWW & INBX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | WWW | INBX |
|---|---|---|
| Founded | 1883 | 2010 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Shoe Manufacturing | Biotechnology: Pharmaceutical Preparations |
| Sector | Consumer Discretionary | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 1.6B | 1.4B |
| IPO Year | 2003 | 2024 |
Fundamental Metrics
Financial Performance| Metric | WWW | INBX |
|---|---|---|
| Price | $21.19 | $88.58 |
| Analyst Decision | Buy | Buy |
| Analyst Count | 10 | 3 |
| Target Price | $24.44 | ★ $150.00 |
| AVG Volume (30 Days) | ★ 764.7K | 191.3K |
| Earning Date | 05-14-2026 | 05-15-2026 |
| Dividend Yield | ★ 2.37% | N/A |
| EPS Growth | ★ 96.55 | N/A |
| EPS | ★ 0.61 | N/A |
| Revenue | ★ $1,874,300,000.00 | $1,300,000.00 |
| Revenue This Year | $6.65 | N/A |
| Revenue Next Year | $5.50 | N/A |
| P/E Ratio | $83.00 | ★ N/A |
| Revenue Growth | 6.80 | ★ 550.00 |
| 52 Week Low | $13.47 | $22.40 |
| 52 Week High | $32.80 | $155.29 |
Technical Indicators
Market Signals| Indicator | WWW | INBX |
|---|---|---|
| Relative Strength Index (RSI) | 64.91 | 48.64 |
| Support Level | $17.09 | $85.94 |
| Resistance Level | $21.18 | $96.12 |
| Average True Range (ATR) | 0.87 | 5.49 |
| MACD | -0.00 | 1.53 |
| Stochastic Oscillator | 98.41 | 46.88 |
Price Performance
Historical ComparisonAbout WWW Wolverine World Wide Inc.
Wolverine World Wide Inc is engaged in designing, manufacturing, sourcing, marketing, licensing, and distributing branded footwear, apparel, and accessories. The company's segment includes Active Group; and Work Group. It generates maximum revenue from the Active Group segment. Active Group segment consists of Merrell footwear and apparel, Saucony footwear and apparel, Sweaty Betty activewear, and Chaco footwear. Geographically, the company operates in United States; Europe, Middle East and Africa; Asia Pacific; Canada; and Latin America.
About INBX Inhibrx Inc.
Inhibrx Biosciences Inc is a clinical-stage biopharmaceutical company with a pipeline of novel biologic therapeutic candidates, developed using its proprietary modular protein engineering platforms. Its clinical pipeline of therapeutic candidates includes INBRX-109 and INBRX-106, both of which utilize their multivalent formats where the precise valency can be optimized in a target-centric way to mediate what experts consider to be the predominant agonist function.